Elsevier's Gold Standard, a drug information provider, has announced that the Northern New England Accountable Care Collaborative, LLC, (NNEACC) has selected the Gold Standard Drug Database to deliver current and accurate drug data and drug decision support. Co-founded by Dartmouth Hitchcock, Eastern Maine Healthcare Systems, Maine Health and Dartmouth College, NNEACC develops, implements and evaluates new models of clinical care required to deliver on the Triple Aim – better care, better health at lower cost.
The integration of the Gold Standard Drug Database module will allow the NNEACC to streamline and automate the process of integrating prescribing data with administrative and clinical information to provide a robust view of patient activity to clinicians.
The Gold Standard Drug Database will offer NNEACC drug pricing updates, therapeutic groupings of drug products, brand versus generic identifiers, and accurate information on generics. The Gold Standard Drug Database interacts intelligently with patient prescribing data to guide the clinician to an efficient and effective delivery of the patient's medication, assisting adherence to drug therapy for best health benefits. NNEACC will benefit from the database's modern technical architecture, combined with current, accurate content and built-in human logic for superior decision support, which distinguishes Gold Standard Drug Database from other drug compendia.
Led by Dr. David Wennberg, the NNEACC solution integrates administrative and clinical data sources in a proven data technology foundation with innovative analytics to provide focused and actionable information that supports clinicians and administrators as they manage care.
